scholarly journals Group Exercise And Over-speed Cycling Effects On Mental Health In Parkinson’s Disease.

2020 ◽  
Vol 52 (7S) ◽  
pp. 141-141
Author(s):  
Emalee Smith ◽  
Josh Waits ◽  
Josh Olson ◽  
Shaina Bodenhofer ◽  
Samuel Miller ◽  
...  
2021 ◽  
pp. 026921552199052
Author(s):  
Zonglei Zhou ◽  
Ruzhen Zhou ◽  
Wen Wei ◽  
Rongsheng Luan ◽  
Kunpeng Li

Objective: To conduct a systematic review evaluating the effects of music-based movement therapy on motor function, balance, gait, mental health, and quality of life among individuals with Parkinson’s disease. Data sources: A systematic search of PubMed, Embase, Cochrane Library, Web of Science, PsycINFO, CINAHL, and Physiotherapy Evidence Database was carried out to identify eligible papers published up to December 10, 2020. Review methods: Literature selection, data extraction, and methodological quality assessment were independently performed by two investigators. Publication bias was determined by funnel plot and Egger’s regression test. “Trim and fill” analysis was performed to adjust any potential publication bias. Results: Seventeen studies involving 598 participants were included in this meta-analysis. Music-based movement therapy significantly improved motor function (Unified Parkinson’s Disease Rating Scale motor subscale, MD = −5.44, P = 0.002; Timed Up and Go Test, MD = −1.02, P = 0.001), balance (Berg Balance Scale, MD = 2.02, P < 0.001; Mini-Balance Evaluation Systems Test, MD = 2.95, P = 0.001), freezing of gait (MD = −2.35, P = 0.039), walking velocity (MD = 0.18, P < 0.001), and mental health (SMD = −0.38, P = 0.003). However, no significant effects were observed on gait cadence, stride length, and quality of life. Conclusion: The findings of this study show that music-based movement therapy is an effective treatment approach for improving motor function, balance, freezing of gait, walking velocity, and mental health for patients with Parkinson’s disease.


2021 ◽  
pp. 1-3
Author(s):  
Eileen Joyce

SUMMARY Clozapine is the only antipsychotic licensed for treatment of Parkinson's disease psychosis (PDP) but is infrequently used in the National Health Service because of obstacles to the integration of hospital-based neurological/geriatric services with clozapine clinics run by community mental health teams. This commentary points out the mismatch between NICE quality standards on antipsychotic treatment for PDP and current clinical practice. It suggests that forthcoming integrated care systems should be able to overcome these obstacles, enabling innovative models for providing clozapine treatment for PDP such as those described by Taylor et al, so that clozapine treatment becomes a right for patients and their families.


2021 ◽  
Vol 75 (Supplement_2) ◽  
pp. 7512500009p1-7512500009p1
Author(s):  
Sarah A. Zurawski ◽  
Kristen A. Pickett ◽  
Maria Widmer

Abstract Date Presented 04/12/21 OT has been specifically called upon to improve the quality of care of people with Parkinson's disease (PD). This capstone project is a response to this call. A two-module online learning program was designed to address the gap between knowledge and current best practices in the treatment of mental health concerns associated with PD. The results suggest that high-quality online training is an effective way to teach OTs to better address the mental health needs of people with PD. Primary Author and Speaker: Sarah A. Zurawski; Contributing Authors: Wendy Coster, Gael Orsmond


2011 ◽  
Vol 18 (12) ◽  
pp. 1746-1747 ◽  
Author(s):  
Rahul Potluri ◽  
Ammar Natalwala ◽  
Mitsuko Nakajima ◽  
Deepthi Lavu ◽  
Rochelle Velho ◽  
...  

1987 ◽  
Vol 12 (5) ◽  
pp. 242-245 ◽  
Author(s):  
Pamela H. Mitchell ◽  
Mary Ann Mertz ◽  
Marci-Lee Catanzaro

Sign in / Sign up

Export Citation Format

Share Document